Ricks: Price Controls Would Mean Cuts at Lilly
As Congress considers a proposal to allow Medicare to negotiate prescription drug prices, Eli Lilly and Co. (NYSE: LLY) Chief Executive Officer Dave Ricks is warning the move would have a devastating... Read More